SuzanneEGleysteenMD
Internal Medicine • Brookline, MAInstructor in Medicine, Beth Israel Deaconess Medical Center
Dr. Gleysteen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
637 Washington St
Suite 100
Brookline, MA 02446Phone+1 617-798-1600Fax+1 617-798-1900
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1991 - 1995
Rutgers Robert Wood Johnson Medical SchoolClass of 1991
Certifications & Licensure
MA State Medical License 1994 - 2025
NH State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 6 citationsSequential therapy with recombinant human IGF-1 followed by risedronate increases spine bone mineral density in women with anorexia nervosa: A randomized, placebo-cont...Melanie S Haines, Allison Kimball, Erinne Meenaghan, Katherine N. Bachmann, Kate Santoso
Journal of Bone and Mineral Research. 2021-09-02 - 77 citationsPeptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosaAndrea L. Utz, Elizabeth A. Lawson, Madhusmita Misra, Diane Mickley, Suzanne Gleysteen
Bone. 2008-07-01 - 97 citationsEffects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study.Karen K. Miller, Erinne Meenaghan, Elizabeth A. Lawson, Madhusmita Misra, Suzanne Gleysteen
The Journal of Clinical Endocrinology and Metabolism. 2011-04-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
